Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Ren

MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

Science Translational Medicine

Medicine

2012

English

P1.01-111 EGFR Exon20 Insertion Patients Treated With First-Line Chemotherapy in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

MA11.05 Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact

Journal of Thoracic Oncology

English

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

Journal of Thoracic Oncology

English

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.12-13 Expression of the Immune Checkpoint Axis-PVR/Tigit in Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.04-13 the Immune Checkpoint, HVEM Contribute to Immune Escape in Non Small Cell Lung Cancer of Lacking PDL1 Expression

Journal of Thoracic Oncology

English

MA15.10 Loss of T790M Mutation Is Associated With Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

Journal of Thoracic Oncology

English

P1.13-26 First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant NSCLC Patients With Oligoprogressive Disease

Journal of Thoracic Oncology

English

OP13.06: The Poor Performance of Prenatal Ultrasound Screening for Congenital CMV Infection Is a Missed Opportunity Calling for Maternal Serological Screening in the First Trimester

Ultrasound in Obstetrics and Gynecology

Nuclear Medicine

Radiology

Ultrasound Technology

Gynecology

Reproductive Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Ren

MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

P1.01-111 EGFR Exon20 Insertion Patients Treated With First-Line Chemotherapy in Non-Small Cell Lung Cancer

MA11.05 Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

P3.12-13 Expression of the Immune Checkpoint Axis-PVR/Tigit in Small Cell Lung Cancer

P2.04-13 the Immune Checkpoint, HVEM Contribute to Immune Escape in Non Small Cell Lung Cancer of Lacking PDL1 Expression

MA15.10 Loss of T790M Mutation Is Associated With Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

P1.13-26 First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant NSCLC Patients With Oligoprogressive Disease

OP13.06: The Poor Performance of Prenatal Ultrasound Screening for Congenital CMV Infection Is a Missed Opportunity Calling for Maternal Serological Screening in the First Trimester